scholarly article | Q13442814 |
P2093 | author name string | Miesfeld RL | |
Chamberlain NL | |||
Driver ED | |||
P2860 | cites work | Biological Actions of Androgens | Q22306226 |
Use of T7 RNA polymerase to direct expression of cloned genes | Q27860692 | ||
Cloning of Human Androgen Receptor Complementary DNA and Localization to the X Chromosome | Q28118052 | ||
Cloning of a transcriptionally active human TATA binding factor | Q28118101 | ||
Primary structure and expression of a functional human glucocorticoid receptor cDNA | Q28282278 | ||
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors | Q29615768 | ||
Gene regulation by steroid hormones | Q29618291 | ||
Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors | Q33651363 | ||
Structural organization and sequence of the homeotic gene Antennapedia of Drosophila melanogaster | Q33879731 | ||
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy | Q34023072 | ||
Cloning, structure and expression of a cDNA encoding the human androgen receptor | Q34049755 | ||
Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism | Q72233686 | ||
Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation | Q72258740 | ||
Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy | Q72635320 | ||
Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait | Q34051849 | ||
Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins | Q34163692 | ||
Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy | Q34231877 | ||
A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure | Q34266153 | ||
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. | Q34353488 | ||
opa: a novel family of transcribed repeats shared by the Notch locus and other developmentally regulated loci in D. melanogaster | Q34563922 | ||
Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups | Q34614818 | ||
Domains of the Human Androgen Receptor Involved in Steroid Binding, Transcriptional Activation, and Subcellular Localization | Q34671706 | ||
Transcriptional activation and nuclear targeting signals of the human androgen receptor. | Q35009652 | ||
Dynamic mutations: a new class of mutations causing human disease | Q35782791 | ||
A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular-feminized mouse | Q35804705 | ||
The rat androgen receptor: primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein | Q36440122 | ||
Androgen resistance caused by mutations in the androgen receptor gene. | Q36831018 | ||
X-linked recessive bulbospinal neuronopathy: a report of ten cases | Q37027303 | ||
Activators and targets | Q37856107 | ||
A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene | Q38313441 | ||
Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors | Q38340343 | ||
Transcriptional repression of eukaryotic promoters | Q38365817 | ||
Cellular analyses of hormone influence on motoneuronal development and function | Q39734145 | ||
Heterogeneity in the polyglutamine tract of the glucocorticoid receptor from different rat strains | Q40406692 | ||
Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis | Q40653917 | ||
Transcriptional activation modulated by homopolymeric glutamine and proline stretches | Q41488003 | ||
Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions | Q41543354 | ||
Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element | Q41572923 | ||
Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene | Q41580505 | ||
Characterization of a panel of rat ventral prostate epithelial cell lines immortalized in the presence or absence of androgens | Q41597156 | ||
Multiple components of a complex androgen-dependent enhancer | Q41658230 | ||
Timing and duration of dihydrotestosterone treatment affect the development of motoneuron number and morphology in a sexually dimorphic rat spinal nucleus | Q41839154 | ||
The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins | Q42080838 | ||
Functional domains of the human glucocorticoid receptor | Q43734761 | ||
Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation | Q43884151 | ||
Structure and size distribution of the androgen receptor mRNA in wild-type and Tfm/Y mutant mice | Q44508084 | ||
Identification of a thyroid hormone receptor that is pituitary-specific | Q44748833 | ||
In vitro transcription enhancement by purified derivatives of the glucocorticoid receptor. | Q46016097 | ||
Aberrant androgen action and increased size of tandem CAG repeat in androgen receptor gene in X-linked recessive bulbospinal neuronopathy | Q47379781 | ||
Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene | Q47404452 | ||
Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID). | Q51166921 | ||
Crossing the threshold. | Q52230019 | ||
[72] Identification of regulatory elements of cloned genes with functional assays | Q62397562 | ||
Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy | Q67600935 | ||
Androgen receptor abnormality in X-linked spinal and bulbar muscular atrophy | Q68028965 | ||
Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation | Q68975768 | ||
Administration of testosterone attenuates neuronal loss following axotomy in the brain-stem motor nuclei of female rats | Q69386582 | ||
Testosterone-induced acceleration of recovery from facial paralysis following crush axotomy of the facial nerve in male hamsters | Q69650080 | ||
Genome projects are growing like weeds | Q69659441 | ||
Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene | Q70651007 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3181-3186 | |
P577 | publication date | 1994-08-01 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function | |
P478 | volume | 22 |
Q37712386 | 2D:4D ratio in children at familial high-risk for eating disorders: The role of prenatal testosterone exposure |
Q28200053 | A candidate prostate cancer susceptibility gene at chromosome 17p |
Q47621371 | A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH. |
Q35605845 | A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). |
Q34113217 | A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
Q44415291 | A multigene test for the risk of sporadic breast carcinoma |
Q34707254 | A novel method for the analysis of the androgen receptor |
Q34698933 | A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission. |
Q34507367 | A potential novel spontaneous preterm birth gene, AR, identified by linkage and association analysis of X chromosomal markers |
Q37270889 | A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis |
Q34565351 | A review of genetic polymorphisms and prostate cancer risk |
Q37387072 | A role for the SHP-2 tyrosine phosphatase in nerve growth-induced PC12 cell differentiation |
Q42792854 | A safety study of administration of parenteral testosterone undecanoate to elderly men over minimally 24 months |
Q33241980 | AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines |
Q30445140 | Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein |
Q56679619 | Advances in male contraception |
Q44399756 | Aerobic exercise and bone mineral density in middle-aged finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor α gene polymorphisms |
Q37282979 | Aggression and polymorphisms in AR, DAT1, DRD2, and COMT genes in Datoga pastoralists of Tanzania |
Q85241142 | Aggression, Digit Ratio and Variation in Androgen Receptor and Monoamine Oxidase A Genes in Men |
Q43939196 | Aggression, digit ratio, and variation in the androgen receptor, serotonin transporter, and dopamine D4 receptor genes in African foragers: the Hadza. |
Q37331263 | Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice |
Q53411360 | Altered expression of androgen-receptor isoforms in human colon-cancer tissues. |
Q51904643 | An increased CAG repeat length in the androgen receptor gene in azoospermic ICSI candidates. |
Q47999661 | Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms |
Q37422378 | Androgen Receptor Gene CAG Repeat Polymorphism Regulates the Metabolic Effects of Testosterone Replacement Therapy in Male Postsurgical Hypogonadotropic Hypogonadism |
Q35751403 | Androgen Receptor Gene Polymorphism, Aggression, and Reproduction in Tanzanian Foragers and Pastoralists |
Q43596593 | Androgen induced cell death in SHSY5Y neuroblastoma cells expressing wild-type and spinal bulbar muscular atrophy mutant androgen receptors. |
Q33869547 | Androgen insensitivity. |
Q34043875 | Androgen receptor (AR) gene CAG trinucleotide repeat length associated with body composition measures in non-syndromic obese, non-obese and Prader-Willi syndrome individuals |
Q27013914 | Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells |
Q47233293 | Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships |
Q33723560 | Androgen receptor CAG repeat length and risk of biliary tract cancer and stones |
Q78439258 | Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype |
Q37523512 | Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial |
Q28475309 | Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome |
Q34287725 | Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer |
Q79222833 | Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population |
Q45065643 | Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. |
Q35209313 | Androgen receptor CAG repeat size is associated with stress fracture risk: a pilot study |
Q35014537 | Androgen receptor CAG repeats length polymorphism and the risk of polycystic ovarian syndrome (PCOS) |
Q44677957 | Androgen receptor GGC polymorphism and testosterone levels associated with high risk of prostate cancer and benign prostatic hyperplasia |
Q34879760 | Androgen receptor and monoamine oxidase polymorphism in wild bonobos |
Q39997315 | Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas |
Q44659948 | Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer |
Q34490999 | Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer |
Q44118558 | Androgen receptor gene CAG(n) trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome |
Q34993797 | Androgen receptor gene and male genital anomaly. |
Q33576938 | Androgen receptor gene and sex-specific Alzheimer's disease |
Q38062708 | Androgen receptor gene polymorphism and polycystic ovary syndrome. |
Q37074233 | Androgen receptor gene polymorphism and sex hormones in elderly men: the Tromsø study |
Q28647118 | Androgen receptor gene polymorphism in zebra species |
Q40244118 | Androgen receptor gene polymorphism influence fat accumulation: A longitudinal study from adolescence to adult age. |
Q35202414 | Androgen receptor gene polymorphisms are associated with aggression in Japanese Akita Inu |
Q54462904 | Androgen receptor gene sequence and basal cortisol concentrations predict men's hormonal responses to potential mates. |
Q40931377 | Androgen receptor phosphorylation |
Q35127580 | Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1. |
Q47227720 | Androgen receptor polyglutamine repeat length (AR-CAGn) modulates the effect of testosterone on androgen-associated somatic traits in Filipino young adult men. |
Q35553247 | Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development |
Q34769670 | Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients |
Q47793235 | Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne |
Q53267259 | Androgen receptor polymorphisms and endometrial cancer risk. |
Q34068244 | Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women |
Q36503027 | Androgen receptor variants and prostate cancer in humanized AR mice. |
Q38780007 | Androgen receptor-related diseases: what do we know? |
Q42261015 | Androgen receptor-target genes in african american prostate cancer disparities |
Q37256846 | Androgen receptor: role and novel therapeutic prospects in prostate cancer |
Q34247095 | Androgen receptors and their biology |
Q24296691 | Androgen regulation of the human FERM domain encoding gene EHM2 in a cell model of steroid-induced differentiation |
Q55357541 | Androgen-Induced Immunosuppression. |
Q24673304 | Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model |
Q41205966 | Androgen-receptor gene structure and function in prostate cancer |
Q35659922 | Androgens and adipose tissue in males: a complex and reciprocal interplay |
Q37084126 | Androgens and male aging: Current evidence of safety and efficacy |
Q30251924 | Anogenital distance as a marker of androgen exposure in humans |
Q21147080 | Anxiety, sex-linked behaviors, and digit ratios (2D:4D) |
Q34446570 | Are there CAG repeat expansion-related disorders outside the central nervous system? |
Q57632738 | Aspectos Moleculares da Determinação e Diferenciação Sexual |
Q42403123 | Assessment of Correlation between Androgen Receptor CAG Repeat Length and Infertility in Infertile Men Living in Khuzestan, Iran |
Q37553969 | Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population. |
Q47782821 | Association between G1733A (rs6152) polymorphism in androgen receptor gene and recurrent spontaneous abortions in Mexican population |
Q45253544 | Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women. |
Q34608698 | Association between genetic polymorphisms in androgen receptor gene and the risk of preeclampsia in Korean women |
Q36661085 | Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome |
Q35889612 | Association of androgen receptor GGN repeat length polymorphism and male infertility in Khuzestan, Iran |
Q56513773 | Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case-control study |
Q48168790 | Association of androgen receptor gene CAG and GGN repeat polymorphism with cryptorchidism: A meta-analysis |
Q54693792 | Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. |
Q51757080 | Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis. |
Q41717834 | BDNF regulation of androgen receptor expression in axotomized SNB motoneurons of adult male rats |
Q34574410 | Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. |
Q34457175 | Behavioral and genetic correlates of the neural response to infant crying among human fathers |
Q37826806 | Bone density and risk of osteoporosis in Klinefelter syndrome |
Q42140110 | Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity |
Q37181453 | CAG Repeat Number in the Androgen Receptor Gene and Prostate Cancer. |
Q79568360 | CAG and CTG repeat polymorphism in exons of human genes shows distinct features at the expandable loci |
Q92004313 | CAG polymorphism in the androgen receptor gene in women may be associated with nodulocystic acne |
Q39272843 | CAG repeat length in androgen receptor gene and male infertility in Egyptian patients. |
Q36619671 | CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk |
Q53201491 | CTG Triplet Repeat in Mouse Growth Inhibitory Factor/Metallothionein III Gene Promoter Represses the Transcriptional Activity of the Heterologous Promoters |
Q92723351 | Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213 |
Q36218806 | Cell-based assays for screening androgen receptor ligands |
Q28509836 | Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form |
Q82029161 | Chapter 8 Spinobulbar muscular atrophy (Kennedy's disease) |
Q58577846 | Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1 |
Q40717386 | Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3. |
Q61446675 | Child sexual offenders show prenatal and epigenetic alterations of the androgen system |
Q39468132 | Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer |
Q34769679 | Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients |
Q42680540 | Cloning and expression analysis of androgen receptor gene in chicken embryogenesis |
Q57744393 | Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer |
Q36430744 | Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model |
Q34047435 | Comparative studies of prostate cancer in Japan versus the United States. A review |
Q90678415 | Comparison of NGS panel and Sanger sequencing for genotyping CAG repeats in the AR gene |
Q46935757 | Comparison of androgen receptor CAG and GGN repeat length polymorphism in humans and apes |
Q51761006 | Comparison of the polymorphisms of androgen receptor gene and estrogen alpha and beta gene between adolescent females with first-onset major depressive disorder and controls. |
Q38572877 | Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management |
Q33802277 | Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer |
Q35809733 | Cortisol and testosterone increase financial risk taking and may destabilize markets |
Q35863711 | Cryptorchidism: diagnosis, treatment, and long-term prognosis |
Q60920049 | Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia |
Q41860888 | Cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch |
Q93081557 | Deficiency in Androgen Receptor Aggravates the Depressive-Like Behaviors in Chronic Mild Stress Model of Depression |
Q41157407 | Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain |
Q73082853 | Determination of CAG repeat length in the androgen-receptor gene using frozen serum |
Q40611725 | Development of models to predict anabolic response to testosterone administration in healthy young men. |
Q37883014 | Differing levels of testosterone and the prostate: a physiological interplay |
Q30405382 | Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease. |
Q37210875 | Diverse roles of androgen receptor (AR) domains in AR-mediated signaling |
Q36773464 | Drug insight: role of the androgen receptor in the development and progression of prostate cancer |
Q55478794 | Effects of androgen receptor polyglutamine tract expansion on proliferation of NG108-15 cells. |
Q90116631 | Endogenous testosterone correlates with parochial altruism in relation to costly punishment in different social settings |
Q35990415 | Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein |
Q44005507 | Epidemiology of prostatic cancer in East Asia |
Q22251432 | Etiologies underlying sex differences in Autism Spectrum Disorders |
Q38291027 | Evidence for association of sex hormone-binding globulin and androgen receptor genes with semen quality. |
Q42868254 | Expression of humoral autoimmunity is related to androgen receptor CAG repeat length in men with systemic lupus erythematosus |
Q47825253 | Expression of steroidogenic enzymes and metabolism of steroids in COS-7 cells known as non-steroidogenic cells. |
Q38662854 | Functional significance of men's testosterone reactivity to social stimuli |
Q34565746 | GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men. |
Q29040033 | Gain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen Receptor |
Q37084474 | Gene-environment interaction and male reproductive function |
Q35989056 | Gene-environment interactions: a review of effects on reproduction and development |
Q37206980 | Genetic Association Between Androgen Receptor Gene CAG Repeat Length Polymorphism and Male Infertility: A Meta-Analysis |
Q53693885 | Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology. |
Q58797229 | Genetic Variation in the Androgen Receptor and Measures of Plasma Testosterone Levels Suggest Androgen Dysfunction in Alzheimer's Disease |
Q53438178 | Genetic alterations of androgen receptor gene in Japanese human prostate cancer. |
Q46922203 | Genetic analysis of a family with 46,XY "female" associated with infertility |
Q38368023 | Genetic and environmental factors in the aetiology of hypospadias. |
Q37139054 | Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men. |
Q38736949 | Genetic architecture of acne vulgaris. |
Q37945125 | Genetic determinants of aggression and impulsivity in humans |
Q35064240 | Genetic diseases in adults |
Q57565186 | Genetic impact on prostate anatomical variability during ageing: role of CYP17, SRD5A2 and androgen receptor genes polymorphisms |
Q35592722 | Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men |
Q35597290 | Genetic polymorphisms and prostate cancer risk |
Q37454788 | Genetic variation in the androgen receptor gene and endometrial cancer risk |
Q34557770 | Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia |
Q38460006 | Genetics of androgen metabolism in women with infertility and hypoandrogenism |
Q82245844 | Genetics of polycystic ovary syndrome |
Q52585939 | Genome-wide association study identifies nine novel loci for 2D:4D finger ratio, a putative retrospective biomarker of testosterone exposure in utero. |
Q36845131 | Genomic biomarkers, androgen pathway and prostate cancer. |
Q34388792 | Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation |
Q40123008 | Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells |
Q35062376 | Handedness and the X chromosome: the role of androgen receptor CAG-repeat length |
Q45944320 | Height, obesity, and the risk of TMPRSS2:ERG-defined prostate cancer. |
Q56928447 | Hereditary breast cancer |
Q35452137 | Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types |
Q35438009 | High frequency of skewed X inactivation in young breast cancer patients |
Q38256197 | Higher androgen bioactivity is associated with excessive erythrocytosis and chronic mountain sickness in Andean Highlanders: a review. |
Q37026024 | Hormonal and genetic control of testicular descent |
Q35102851 | Hormonal prevention of prostate cancer |
Q37721629 | Hormonal profile and androgen receptor study in prepubertal girls with hypertrichosis |
Q34732880 | Hormones and prostate cancer: current perspectives and future directions |
Q35687198 | Hormones and prostate carcinogenesis: Androgens and estrogens |
Q41084579 | How is individual risk for prostate cancer assessed? |
Q34360616 | Human prostate cancer risk factors |
Q91992695 | Human reproductive behavior, life history, and the Challenge Hypothesis: A 30-year review, retrospective and future directions |
Q89049086 | Human social neuroendocrinology: Review of the rapid effects of testosterone |
Q81158385 | Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology |
Q73483127 | Implications of a polyglutamine tract in the function of the human androgen receptor |
Q26825204 | In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production |
Q26784181 | Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action |
Q35661289 | Influence of Low-Level Prenatal Exposure to PCDD/Fs and PCBs on Empathizing, Systemizing and Autistic Traits: Results from the Duisburg Birth Cohort Study. |
Q37173763 | Influence of androgen receptor repeat polymorphisms on personality traits in men |
Q42005831 | Influence of short polyglutamine tracts and p160 coactivators on the transactivation of the androgen receptor |
Q34580741 | Inherited predisposition and breast cancer: modifiers of BRCA1/2-associated breast cancer risk |
Q35554127 | Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression |
Q40859984 | Intracellular processing and toxicity of the truncated androgen receptor: nuclear congophilia-associated cell death |
Q38357468 | Invasion of the CAG triplet repeats by a complementary peptide nucleic acid inhibits transcription of the androgen receptor and TATA-binding protein genes and correlates with refolding of an active nucleosome containing a unique AR gene sequence |
Q45227254 | Investigation of hormone receptor genes in migraine. |
Q91564675 | Is testosterone linked to human aggression? A meta-analytic examination of the relationship between baseline, dynamic, and manipulated testosterone on human aggression |
Q34549670 | Isolation of active genes containing CAG repeats by DNA strand invasion by a peptide nucleic acid |
Q36371585 | Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man. |
Q35828195 | Lack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide |
Q58486177 | Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer |
Q43917963 | Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men. |
Q80448216 | Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia |
Q35141431 | Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo |
Q34707086 | Linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in the African-American population |
Q41667978 | Localization of functional domains in the androgen receptor |
Q64092194 | Long-read single-molecule maps of the functional methylome |
Q30496813 | Longitudinally mapping the influence of sex and androgen signaling on the dynamics of human cortical maturation in adolescence |
Q34055364 | Macroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice |
Q56227763 | Male breast cancer |
Q28477819 | Male germ cell-specific RNA binding protein RBMY: a new oncogene explaining male predominance in liver cancer |
Q36395111 | Mechanisms of disease: Polymorphisms of androgen regulatory genes in the development of prostate cancer |
Q33976024 | Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells |
Q27008271 | MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans |
Q41887497 | Microsatellites with macro-influence in ewing sarcoma |
Q34160987 | Microsatellites: genomic distribution, putative functions and mutational mechanisms: a review |
Q24545497 | Mini- and microsatellites |
Q47874782 | Minimum CAG repeat in the human calmodulin-1 gene 5' untranslated region is required for full expression |
Q33633160 | Minireview: the molecular and genomic basis for prostate cancer health disparities |
Q34389571 | Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat |
Q35084790 | Modifiers of risk of hereditary breast and ovarian cancer |
Q35024939 | Molecular Basis of Steroid Action in the Prostate |
Q34491450 | Molecular action of androgen in the normal and neoplastic prostate |
Q42725273 | Molecular analysis of the androgen receptor gene in Hong Kong Chinese infertile men |
Q44360255 | Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation |
Q41334556 | Molecular basis for prostate cancer racial disparities. |
Q52538313 | Molecular basis of androgen receptor diseases. |
Q33816588 | Molecular biology of prostate carcinogenesis |
Q28587802 | Molecular cloning and characterization of a novel mouse macrophage gene that encodes a nuclear protein comprising polyglutamine repeats and interspersing histidines |
Q48238211 | Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia |
Q30720277 | Molecular cloning and functional characterization of the canine androgen receptor |
Q58136321 | Molecular genetics of prostate cancer |
Q34566518 | Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer |
Q34769413 | Molecular mechanism of androgen action |
Q45327318 | Molecular mechanisms involving prostate cancer racial disparity |
Q37418937 | Molecular mechanisms involving prostate cancer racial disparity. |
Q46101484 | Molecular organization of 5S rDNAs in Rajidae (Chondrichthyes): Structural features and evolution of piscine 5S rRNA genes and nontranscribed intergenic spacers. |
Q28306876 | Molecular pathology of the androgen receptor in male (in)fertility |
Q33962326 | Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors |
Q33965424 | Multiple Domains Define the Expression and Regulatory Properties of Foxp1 Forkhead Transcriptional Repressors |
Q24554443 | Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins |
Q37732743 | Mutational Analysis of Androgen Receptor (AR) Gene in 46,XY Patients with Ambiguous Genitalia and Normal Testosterone Secretion: Endocrinological Characteristics of Three Patients with AR Gene Mutations |
Q40682633 | Mutations flanking the polyglutamine repeat in the modulatory domain of rat glucocorticoid receptor lead to an increase in affinity for hormone |
Q46323996 | N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function |
Q36277936 | Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis |
Q57296926 | Neuroendocrine stress response is moderated by sex and sex hormone receptor polymorphisms |
Q39207785 | New single nucleotide variation in the promoter region of androgen receptor (AR) gene in hypospadic patients |
Q37365761 | No Evidence that 2D:4D is Related to the Number of CAG Repeats in the Androgen Receptor Gene |
Q41756427 | Nuclear receptors: structure, function and involvement in disease |
Q57269129 | Number of X-linked androgen receptor gene CAG repeats and femininity in women |
Q48291079 | Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions. |
Q27007098 | Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy |
Q30405294 | Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy |
Q38238162 | Perspectives in Pediatric Pathology, Chapter 6. Male Undermasculinization |
Q34189642 | Pharmacogenetics of human androgens and prostatic diseases |
Q92625312 | Physiological and Pathological Androgen Actions in the Ovary |
Q35198263 | Polycystic ovary syndrome woman with heterozygous androgen receptor gene mutation who gave birth to a child with androgen insensitivity syndrome |
Q73375094 | Polyglutamine repeat length influences human androgen receptor/c-Jun mediated transcription |
Q34446532 | Polyglutamine tract expansion of the androgen receptor in a motoneuronal model of spinal and bulbar muscular atrophy. |
Q52738092 | Polyglutamine tracts as modulators of transcriptional activation from yeast to mammals. |
Q82458859 | Polymorphic (CAG)n repeats in the androgen receptor gene: a risk marker for endometriosis and uterine leiomyomas |
Q35548715 | Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis |
Q24791382 | Polymorphic repeat in AIB1 does not alter breast cancer risk |
Q57634565 | Polymorphic repeats in the androgen receptor gene in high-risk sibships |
Q39433516 | Polymorphisms in sex steroid receptors: From gene sequence to behavior. |
Q44124773 | Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis |
Q36263116 | Polymorphisms in the vitamin D receptor and the androgen receptor gene associated with the risk of urolithiasis |
Q41058628 | Polymorphisms of the glucocorticoid receptor gene in laboratory and wild rats: steroid binding properties of trinucleotide CAG repeat length variants |
Q46729134 | Preeclampsia and androgen receptor gene CAG repeat length: results from both children and women |
Q88646934 | Preliminary evidence that androgen signaling is correlated with men's everyday language |
Q38905604 | Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor Signaling. |
Q35547017 | Prostate Development and Carcinogenesis |
Q38683379 | Prostate cancer in men of African origin. |
Q28508802 | Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium |
Q33812889 | Racial differences in the androgen/androgen receptor pathway in prostate cancer. |
Q57943193 | Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis |
Q64055629 | Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms |
Q36287950 | Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. |
Q77229014 | Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor |
Q46683533 | Reduced CAG repeats length in androgen receptor gene is associated with violent criminal behavior |
Q28611237 | Regulation of androgen action |
Q43759819 | Relationship between expansion of the CAG repeat in exon 1 of the androgen receptor gene and idiopathic male infertility |
Q33621461 | Relationships among androgen receptor CAG repeat polymorphism, sex hormones and penile length in Han adult men from China: a cross-sectional study |
Q38181427 | Relevance of genetic investigation in male infertility. |
Q36277189 | Repeat instability: mechanisms of dynamic mutations |
Q37361212 | Rescue of Metabolic Alterations in AR113Q Skeletal Muscle by Peripheral Androgen Receptor Gene Silencing. |
Q34219464 | Revisiting the role of antiandrogen strategies in ovarian cancer |
Q91791514 | Role for androgens in determination of ovarian fate in the common snapping turtle, Chelydra serpentina |
Q90442504 | Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review) |
Q33851770 | Role of androgen receptor CAG repeat polymorphism and X-inactivation in the manifestation of recurrent spontaneous abortions in Indian women |
Q21195191 | Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide |
Q40951040 | Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome. |
Q33675144 | Salivary testosterone and a trinucleotide (CAG) length polymorphism in the androgen receptor gene predict amygdala reactivity in men |
Q34630761 | Second to fourth digit ratio: a predictor of adult penile length |
Q85040440 | Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women |
Q54290846 | Semen quality is influenced by androgen receptor and aromatase gene synergism. |
Q37397526 | Serum organochlorine pesticide residues and risk of testicular germ cell carcinoma: a population-based case-control study |
Q46555023 | Serum resistin and polymorphisms of androgen receptor GAGn and GGNn and aromatase TTTAn |
Q39525050 | Serum testosterone levels in African-American and white men undergoing prostate biopsy |
Q38878236 | Sex Hormones and Cognition: Neuroendocrine Influences on Memory and Learning |
Q57316581 | Sex hormone receptor gene variation associated with phenotype in male hypertrophic cardiomyopathy patients |
Q34772485 | Sex hormones and liver cancer |
Q36737983 | Sex steroid-related candidate genes in psychiatric disorders. |
Q90288514 | Sex-Specific Associations of Androgen Receptor CAG Trinucleotide Repeat Length and of Raloxifene Treatment with Testosterone Levels and Perceived Stress in Schizophrenia |
Q40092714 | Short androgen receptor poly-glutamine-promoted endometrial cancer is associated with benzo[a]pyrene-mediated aryl hydrocarbon receptor activation. |
Q46145087 | Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome |
Q34102095 | Significance of the polyglutamine tract polymorphism in the androgen receptor |
Q34738348 | Simple sequence repeats as a source of quantitative genetic variation |
Q33273791 | Simple sequence repeats in zebra finch (Taeniopygia guttata) expressed sequence tags: a new resource for evolutionary genetic studies of passerines |
Q36469802 | Single nucleotide polymorphisms: early diagnosis and risk assessment in genitourinary malignancy |
Q46619826 | Soccer players awarded one or more red cards exhibit lower 2D:4D ratios |
Q61449459 | Somatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instability |
Q34603312 | Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma |
Q34488237 | South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer |
Q57826122 | Spatial Abilities in Prepubertal Intellectually Gifted Boys and Genetic Polymorphisms Related to Testosterone Metabolism |
Q34631186 | Steroid receptors in human breast tumorigenesis and breast cancer progression |
Q36714838 | StuI polymorphism on the androgen receptor gene is associated with recurrent spontaneous abortion. |
Q46816648 | Synergistic effect of follicle-stimulating hormone receptor and androgen receptor gene variants on semen quality |
Q33938808 | Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study |
Q77223275 | Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men |
Q37853838 | Testicular germ cell tumours: predisposition genes and the male germ cell niche. |
Q47375701 | Testosterone administration does not affect men's rejections of low ultimatum game offers or aggressive mood |
Q47641814 | Testosterone and androgen receptor gene polymorphism are associated with confidence and competitiveness in men. |
Q35064997 | Testosterone deficiency and mood in aging men: pathogenic and therapeutic interactions |
Q43728711 | Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. |
Q35684578 | Testosterone metabolism, dose-response relationships and receptor polymorphisms: selected pharmacological/toxicological considerations on benefits versus risks of testosterone therapy in men. |
Q44173664 | Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy |
Q36303823 | Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer? |
Q24810265 | The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women |
Q75204922 | The CAG repeat polymorphism in the androgen receptor gene (AR) and its relationship to head and neck cancer |
Q43917960 | The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males |
Q34483532 | The CAG repeat polymorphism in the androgen receptor gene modifies the risk for hypospadias in Caucasians |
Q39484078 | The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia |
Q36085009 | The CAG repeat within the androgen receptor gene and its relationship to prostate cancer |
Q45269025 | The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients. |
Q35676497 | The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma. |
Q28553212 | The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene |
Q89963927 | The Relation Between Steroid Secretion Patterns and the Androgen Receptor Gene Polymorphism on Physical Health and Psychological Well-Being-Longitudinal Findings From the Men's Health 40+ Study |
Q64245953 | The Role of Androgen Receptor Signaling in Ovarian Cancer |
Q34096288 | The Role of Androgens in Normal and Malignant Breast Tissue |
Q37603742 | The Second-to-Fourth Digit Ratio in Cryptorchidism: A Case-Control Study |
Q37714440 | The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine Disease |
Q42562784 | The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study |
Q77753509 | The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer |
Q24797305 | The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers |
Q34772530 | The androgen receptor CAG repeat: a modifier of carcinogenesis? |
Q73549450 | The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer |
Q34395691 | The androgen receptor gene and its influence on the development and progression of prostate cancer |
Q37074481 | The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancer. |
Q35193278 | The androgen receptor: structure, mutations, and antiandrogens |
Q36236084 | The androgen receptor: unlocking the secrets of its unique transactivation domain |
Q34145721 | The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis |
Q50133280 | The association between glutamine repeats in the androgen receptor gene and personality traits in dromedary camel (Camelus dromedarius). |
Q37204533 | The biological effects of simple tandem repeats: lessons from the repeat expansion diseases |
Q44529187 | The coactivator p/CIP/SRC-3 facilitates retinoic acid receptor signaling via recruitment of GCN5. |
Q57632581 | The degree of external genitalia virilization in girls with 21-hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene |
Q46118080 | The effect of CAG repeat length polymorphism in the murine glucocorticoid receptor on transactivation potential |
Q55162411 | The effect of CAG repeats length on differences in hirsutism among healthy Israeli women of different ethnicities. |
Q50135033 | The endocrinology of human caregiving and its intergenerational transmission |
Q35123242 | The epidemiology of prostate cancer |
Q40690270 | The interaction of serum testosterone levels and androgen receptor CAG repeat polymorphism on the risk of erectile dysfunction in aging Taiwanese men. |
Q37000744 | The latest options and future agents for treating male hypogonadism |
Q39932932 | The modulating effect of the androgen receptor on craving in alcohol withdrawal of men is partially mediated by leptin. |
Q38614574 | The neurobiological basis of human aggression: A review on genetic and epigenetic mechanisms |
Q48368882 | The number of CAG and GGN triplet repeats in the Androgen Receptor gene exert combinatorial effect on hormonal and sperm parameters in young men. |
Q46390903 | The origins of extraversion: joint effects of facultative calibration and genetic polymorphism |
Q38901971 | The orphan GPCR, Gpr161, regulates the retinoic acid and canonical Wnt pathways during neurulation |
Q35750034 | The perinatal androgen to estrogen ratio and autistic-like traits in the general population: a longitudinal pregnancy cohort study |
Q38003702 | The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy |
Q47097766 | The polyglutamine-expanded androgen receptor has increased DNA binding and reduced transcriptional activity |
Q74555292 | The polymorphic CAG repeat in the androgen receptor gene in Jewish Israeli women with endometrial carcinoma |
Q59238477 | The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40 |
Q31159652 | The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men. |
Q45249317 | The relationship between CAG repeat length polymorphism and infertility in Southern Chinese Han women |
Q42140450 | The relationship between anogenital distance and the androgen receptor CAG repeat length. |
Q81612086 | The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer |
Q26992207 | The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans |
Q37660904 | The role of SRC-3 in human breast cancer |
Q24792607 | The role of X-chromosome inactivation in female predisposition to autoimmunity |
Q36760784 | The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS |
Q24803613 | The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer |
Q34930044 | The role of androgens and the androgen receptor in prostate cancer |
Q37145218 | The role of testosterone in the pathogenesis of prostate cancer |
Q56115438 | The second to fourth digit ratio and variation in the androgen receptor gene |
Q36274375 | Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: the CARDIA Male Hormone Study |
Q41169482 | Transcriptional activation and transient expression of the human androgen receptor |
Q34001953 | Transcriptional dysregulation in Huntington's disease |
Q35113556 | Transcriptional intermediary factor 1alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators |
Q73428107 | Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility |
Q57190619 | Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer |
Q35025253 | Trinucleotide repeat disease. The androgen receptor in spinal and bulbar muscular atrophy |
Q40959214 | Trinucleotide repeat expansion and human disease |
Q38551802 | Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention? |
Q103025524 | Uncovering Mitochondrial Determinants of Racial Disparities in Ovarian Cancer |
Q43650580 | Undermasculinized genitalia in a boy with an abnormally expanded CAG repeat length in the androgen receptor gene. |
Q37878799 | Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects |
Q34751856 | Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers |
Q49101957 | Variation in CAG repeat length of the androgen receptor gene predicts variables associated with intrasexual competitiveness in human males |
Q30570172 | Variation in candidate genes CLOCK and ADCYAP1 does not consistently predict differences in migratory behavior in the songbird genus Junco. |
Q33576486 | Variation in the androgen receptor gene exon 1 CAG repeat correlates with manifestations of autoimmunity in women with lupus |
Q61051650 | X chromosome inactivation in cervical cancer patients |
Search more.